Showing 1 - 10 of 693
I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...
Persistent link: https://www.econbiz.de/10011954334
generics where there is no additional federal designation required for substitution. After revealing the existence and extent …
Persistent link: https://www.econbiz.de/10014087594
Do healthcare providers pick their patients? This paper uses patient-level administrative data on skilled nursing facilities in California to estimate a structural model of selective admission practices in the nursing home industry. I exploit within-facility covariation between occupancy and...
Persistent link: https://www.econbiz.de/10013235001
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10010224844
Persistent link: https://www.econbiz.de/10010517752
Persistent link: https://www.econbiz.de/10012182277
Persistent link: https://www.econbiz.de/10010415279
insurance were exempt from the copayments, this health-care reform can be regarded as a natural experiment. We used a difference …
Persistent link: https://www.econbiz.de/10010310720
copayments (specific reimbursements). We show that the induced equilibrium with copayments involves a lower producer price and a …
Persistent link: https://www.econbiz.de/10012581345
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at death), hospital utilization, and medical expenditure in Greece during the period 1995 - 2010. The estimates indicate that pharmaceutical innovation increased mean age at death...
Persistent link: https://www.econbiz.de/10010473542